0 results for 'Janssen Biotech, Inc.'
Latham Breaks Records Again as Revenue Soars, Profit Jumps
Latham pulled in nearly $3.4 billion in its 10th straight year of revenue growth, as the firm's leadership says clients are seeking out its lawyers in more places than ever.Latham Breaks Records Again as Revenue Soars, Profit Jumps
Latham pulled in nearly $3.4 billion in its 10th straight year of revenue growth, as the firm's leadership says clients are seeking out its lawyers in more places than ever.Latham Breaks Records Again as Revenue Soars, Profit Jumps
The firm in January hired David Beller, a private equity and M&A lawyer, from Paul Weiss Rifkind Wharton & Garrison in New York. Latham also lured Alexander Johnson, former head of the M&A practice in the Manhattan offices of Hogan Lovells.Litigators of the Week: Latham's Lethal IP Litigators Kill Patent Challenge to $2B-a-Year Drug
Latham & Watkins global IP co-chair Michael Morin and partner David Frazier delivered a save worth billions to clients Janssen Biotech Inc. and Genmab A/S.Daily Dicta: Gwyneth Paltrow Slammed with $3M Suit for Utah Ski Collision
'Gwyneth Paltrow knew it was wrong to slam into Dr. Sanderson's back, knocking him down, landing on top of him, knocking him out and then leave the scene of the ski crash she caused,' states the complaint filed in Utah state court.Latham Blocks Patent Attack on $2 Billion-a-Year Blood Cancer Drug
MorphoSys and Kirkland & Ellis had accused a Janssen Pharmaceuticals biologic of infringing, but Judge Leonard Stark ruled MorphoSys' patents invalid for lack of enablement.Latham Defeats Patent Attack on $2 Billion-a-Year Blood Cancer Drug
MorphoSys and Kirkland & Ellis had accused a Janssen Pharmaceuticals biologic of infringing, but Judge Leonard Stark ruled MorphoSys' patents invalid for lack of enablement.Court appointed single-firm structure for interim class counsel where risks of increased costs and difficulty in managing multi-firm structure outweighed any benefits multi-firm structure had in effectively serving prospective class. Plaintiffs application to appoint interim class counsel granted.
The court construed disputed terms in this patent infringement matter involving pharmaceuticals.
Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now